---
title: "ROSEMONT PHARMA LIQUIDS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f3ec196d-969e-554f-b1c0-352ffa7250ff
json: https://whiteintel.dev/api/public/dossier/f3ec196d-969e-554f-b1c0-352ffa7250ff
identifier: oo:GB-COH-13436394
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ROSEMONT PHARMA LIQUIDS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-13436394`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f3ec196d-969e-554f-b1c0-352ffa7250ff  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f3ec196d-969e-554f-b1c0-352ffa7250ff  

## Ownership & control

### Owners / controllers

- **ROSEMONT PHARMACEUTICALS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/5f0b62fb-7162-59f0-b1b8-52943f25b8f7
- **Guy Semmens** (beneficial owner) — 50% — https://whiteintel.dev/entity/0ccb6153-a1c3-5bf4-a0af-3c54e2f0aaed
- **Cortex 3 Guernsey Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/24414c85-d5ca-42fd-933c-36180ce59082
- **Guy Semmens** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/0730dcb8-7f0e-4061-a484-d48cc1e757fd
- **ROSEMONT PHARMACEUTICALS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/5f0b62fb-7162-59f0-b1b8-52943f25b8f7

### UBO chain (walk to the ultimate owner)

A **27-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `13436394`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2021-06-03
- **Registered office:** Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, England
- **SIC:** 21100, 46460

### Officers

- FAWCETT, Iain — director · British · appointed 2021-11-22
- WOOD, Gavin — director · British · appointed 2025-12-17
- ASH, Benjamin Matthew — director · British · appointed 2021-06-03 · resigned 2021-11-22
- BUSBY, Timothy Mark — director · English · appointed 2021-11-22 · resigned 2026-01-21
- LIBORG, Ingvild — director · Norwegian · appointed 2021-06-03 · resigned 2021-11-22
- TAYLOR, Howard Langton — director · British · appointed 2021-11-22 · resigned 2025-07-23
- VANGSGAARD, Steen — director · Danish · appointed 2021-06-03 · resigned 2021-11-22

### Beneficial owners (Persons with Significant Control)

- [Rosemont Pharmaceuticals Limited](https://whiteintel.dev/entity/5f0b62fb-7162-59f0-b1b8-52943f25b8f7) — 75–100% shares · corporate PSC · England — since 2021-11-22
- Guy Semmens — 25–50% shares · individual PSC · England — ceased 2021-11-22
- [Cortex 3 Guernsey Limited](https://whiteintel.dev/entity/24414c85-d5ca-42fd-933c-36180ce59082) — 25–50% shares · corporate PSC · Guernsey — ceased 2021-11-22

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/13436394
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/13436394

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ROSEMONT PHARMA LIQUIDS LIMITED** — https://whiteintel.dev/entity/f3ec196d-969e-554f-b1c0-352ffa7250ff · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ROSEMONT PHARMA LIQUIDS LIMITED**. Human view: https://whiteintel.dev/entity/f3ec196d-969e-554f-b1c0-352ffa7250ff · Structured JSON: https://whiteintel.dev/api/public/dossier/f3ec196d-969e-554f-b1c0-352ffa7250ff._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._